Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castrationA Dupont, H Boucher, L Cusan, et al.
The American Journal of Medicine|May 1, 1992
Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case reportJ L Gomez, A Dupont, L Cusan, et al.
Endocrinology|August 1, 1978
Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamideG Pelletier, L Cusan, C Auclair, et al.
Journal of the American Academy of Dermatology|September 1, 1990
Treatment of hirsutism with the pure antiandrogen flutamideL Cusan, A Dupont, A Bélanger, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 1997
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal womenF Labrie, P Diamond, L Cusan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2007
Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal womenF Labrie, A Bélanger, C Labrie, et al.
Molecular and Cellular Endocrinology|January 1, 1981
Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the ratC Séguin, L Cusan, A Bélanger, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case reportF Labrie, A Dupont, A Bélanger, et al.
Anticancer Research|March 1, 1994
Stratification of stage D2 prostate cancer patients by a disease aggressiveness score and its use in evaluating disease response and outcome to combination hormonal treatment (GnRH-A plus flutamide)M Koutsilieris, A Dupont, J Gomez, et al.
L'Union Medicale Du Canada|April 1, 1978
[Inhibition of gonadal function by LHRH and their agonists in the male and female rat]C Auclair, L Cusan, G S Kledzik, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castrationA Dupont, H Boucher, L Cusan, et al.
The American Journal of Medicine|May 1, 1992
Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case reportJ L Gomez, A Dupont, L Cusan, et al.
Endocrinology|August 1, 1978
Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamideG Pelletier, L Cusan, C Auclair, et al.
Journal of the American Academy of Dermatology|September 1, 1990
Treatment of hirsutism with the pure antiandrogen flutamideL Cusan, A Dupont, A Bélanger, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 1997
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal womenF Labrie, P Diamond, L Cusan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2007
Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal womenF Labrie, A Bélanger, C Labrie, et al.
Molecular and Cellular Endocrinology|January 1, 1981
Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the ratC Séguin, L Cusan, A Bélanger, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case reportF Labrie, A Dupont, A Bélanger, et al.
Anticancer Research|March 1, 1994
Stratification of stage D2 prostate cancer patients by a disease aggressiveness score and its use in evaluating disease response and outcome to combination hormonal treatment (GnRH-A plus flutamide)M Koutsilieris, A Dupont, J Gomez, et al.
L'Union Medicale Du Canada|April 1, 1978
[Inhibition of gonadal function by LHRH and their agonists in the male and female rat]C Auclair, L Cusan, G S Kledzik, et al.
Pageof 10